Pfizer’s Hair-Loss Oral Treatment Litfulo Gets FDA Approval

By Sabela Ojea

Pfizer said Friday the Food and Drug Administration has approved Litfulo, its oral treatment for alopecia.

The healthcare company said Litfulo can treat patients aged 12 years and older, becoming the only medication approved by the FDA for adolescents with severe alopecia areata.